HOME >> BIOLOGY >> NEWS
Tracking and treating toxic waste in urban neighborhoods

Abandoned factories and contaminated soil can stall efforts to revive blighted urban neighborhoods. That's because city officials, developers and nearby residents often share common concerns: Is it safe to rebuild here? Will workers and residents become ill from toxic materials that escape into the air and water supplies?

A new research center, led by engineers and scientists at The Johns Hopkins University, plans to address these fears by creating new tools to gauge risks associated with hazardous waste sites and by developing new ways to clean up harmful pollutants. The U.S. Environmental Protection Agency recently approved a five-year $5.2 million grant to launch this new Center for Hazardous Substances in Urban Environments, based at Johns Hopkins. The funds will support research and allow center participants to provide technical help to community groups, state, municipal and local environmental regulators and industry representatives in the Northeast. Researchers from four other institutions the University of Maryland, Morgan State University, the University of Connecticut and the New Jersey Institute of Technology will participate in the new center and share in the EPA grant.

"Before we applied for this grant, we asked regional EPA officials about the most serious challenges they faced," said Ed Bouwer, a Johns Hopkins professor of geography and environmental engineering who serves as the center's director. "One of the top issues they mentioned was urban livability making sure that people in cities have air, water and soil that will not expose them to toxic substances. The other big issue was brownfields abandoned lots and buildings that may contain hazardous materials. If you can redevelop these properties, you can create jobs and improve the tax base. So the cities and states have an economic incentive to promote new construction on the brownfields if the environmental concerns can be addressed."

That's where the new center comes in
'"/>

Contact: Phil Sneiderman
prs@jhu.edu
410-516-7907
Johns Hopkins University
27-Dec-2001


Page: 1 2 3

Related biology news :

1. Tracking climate change
2. Tracking cystic fibrosis with mice
3. Tracking the illegal ivory trade
4. Tracking every egg? AAAS report lists practical options for regulating human cloning
5. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
6. Satellites vs. mosquitoes: Tracking West Nile Virus in the U.S.
7. Tracking path of virulent bacteria via the web
8. Tracking a genetic basis for alcohol-related hypertension
9. Fat In Spite Of Hard Farm Work - Tracking Down Obesity
10. Tracking A Legacy Of Waste In The West Siberian Basin
11. International Expert To Discuss Ramifications At Local Lecture...Tracking Contaminants In The Mighty Mississippi And Other Large Rivers Worldwide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... and HAMILTON, Bermuda , Feb. ... ADXS ) and SELLAS Life ... on developing cancer immunotherapies, today announced that Advaxis ... novel cancer immunotherapy agent using Advaxis, proprietary ... WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change ... advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. ...
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
Breaking Biology Technology:
Cached News: